Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
EU Says Nitrosamine Risk Info Also Needed For New Drug Filings
Incomplete Info May Impact Granting Of Marketing Authorization
Jan 13 2020
•
By
Vibha Sharma
EU Has Updated Guidance On Nitrosamine Risk Evaluations • Source: Shutterstock
More from Manufacturing
More from Compliance